S., Arnold, K., Mackenzie, C., et al
In a multicenter study of 146 patients with painful DPN for 1 to 5 years and a pain score of 40 mm on the Short-Form McGill Pain Questionnaire or an ADP score of 4 on an 11-point pain numerical rating scale (NRS), pregabalin significantly reduced the mean pain score compared with placebo (pregabalin, from 6.5 to 4.0
Phase 2 (Jastreboff 2023) cutaneous category 12.9% at 12 mg vs 1.4% placebo
Compared with group C, the levels of HCT and Hb in group D were significantly decreased
Each form has its own benefits, and professional guidance ensures optimal outcomes for international patients visiting Turkey for trusted care
The PlexusDx Precision Peptide Genetic Test examines 14 pathways and 150+ genetic insights, including GLP1R and MC4R variants that influence digestive sensitivity